GPR17 and glioblastoma: The downstream signaling pathwaysincluding calcium and cAMP mobilization of the lead compound are investigatedto validate the activating GPR17 ability of the synthesized compound.The ability to inhibit the GBM cell growth of the top compound isalso investigated to elucidate its cytotoxicity effect against GBMproliferation.